![](/img/cover-not-exists.png)
Elvitegravir/cobicistat/emtricitabine/tenofovir DF (Quad) has durable efficacy and differentiated safety compared to efavirenz/emtricitabine/tenofovir DF at week 96 in treatment-naïve HIV-1-infected patients
Zolopa, A, Gallant, J, Cohen, C, Sax, P, Dejesus, E, Mills, A, Wohl, D, Liu, H, Rhee, M, Szwarcberg, JVolume:
15
Language:
english
Journal:
Journal of the International AIDS Society
DOI:
10.7448/IAS.15.6.18219
Date:
November, 2012
File:
PDF, 179 KB
english, 2012